KIA
IBB icon

KCM Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

KCM Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32M Sell
13,742
-205
-1% -$35.1K 0.08% 147
2025
Q4 		$2.35M Sell
13,947
-590
-4% -$95.8K 0.08% 150
2025
Q3 		$2.1M Sell
14,537
-529
-4% -$72.2K 0.07% 158
2025
Q2 		$1.91M Sell
15,066
-4,430
-23% -$544K 0.06% 162
2025
Q1 		$2.49M Sell
19,496
-689
-3% -$93.4K 0.09% 139
2024
Q4 		$2.67M Sell
20,185
-196
-1% -$27.6K 0.09% 135
2024
Q3 		$2.97M Sell
20,381
-469
-2% -$67.9K 0.1% 135
2024
Q2 		$2.86M Sell
20,850
-72
-0.3% -$9.61K 0.1% 125
2024
Q1 		$2.87M Sell
20,922
-185
-0.9% -$25.3K 0.11% 126
2023
Q4 		$2.87M Sell
21,107
-1,368
-6% -$167K 0.11% 125
2023
Q3 		$2.75M Sell
22,475
-507
-2% -$64.5K 0.12% 127
2023
Q2 		$2.92M Sell
22,982
-610
-3% -$79.2K 0.12% 131
2023
Q1 		$3.05M Sell
23,592
-1,000
-4% -$131K 0.12% 133
2022
Q4 		$3.23M Sell
24,592
-1,225
-5% -$158K 0.14% 122
2022
Q3 		$3.02M Buy
25,817
+155
+0.6% +$19.2K 0.14% 124
2022
Q2 		$3.02M Sell
25,662
-20,538
-44% -$2.44M 0.13% 125
2022
Q1 		$6.02M Sell
46,200
-4,091
-8% -$533K 0.22% 98
2021
Q4 		$7.67M Sell
50,291
-757
-1% -$117K 0.27% 86
2021
Q3 		$8.25M Sell
51,048
-665
-1% -$112K 0.33% 70
2021
Q2 		$8.46M Buy
51,713
+144
+0.3% +$22.2K 0.34% 68
2021
Q1 		$7.76M Sell
51,569
-464
-0.9% -$73.7K 0.34% 68
2020
Q4 		$7.88M Buy
52,033
+217
+0.4% +$31K 0.38% 65
2020
Q3 		$7.02M Buy
51,816
+11,475
+28% +$1.56M 0.39% 59
2020
Q2 		$5.51M Buy
40,341
+125
+0.3% +$15.9K 0.31% 75
2020
Q1 		$4.33M Sell
40,216
-4,855
-11% -$559K 0.29% 77
2019
Q4 		$5.43M Sell
45,071
-3,055
-6% -$341K 0.3% 85
2019
Q3 		$4.79M Sell
48,126
-4,555
-9% -$477K 0.28% 90
2019
Q2 		$5.75M Sell
52,681
-111
-0.2% -$11.8K 0.34% 82
2019
Q1 		$5.9M Sell
52,792
-2,747
-5% -$301K 0.38% 73
2018
Q4 		$5.36M Sell
55,539
-1,420
-2% -$151K 0.35% 74
2018
Q3 		$6.95M Sell
56,959
-564
-1% -$66.4K 0.4% 66
2018
Q2 		$6.32M Sell
57,523
-645
-1% -$69K 0.39% 67
2018
Q1 		$6.21M Sell
58,168
-930
-2% -$103K 0.38% 70
2017
Q4 		$6.31M Sell
59,098
-1,103
-2% -$118K 0.37% 71
2017
Q3 		$6.69M Sell
60,201
-1,755
-3% -$188K 0.41% 70
2017
Q2 		$6.4M Buy
61,956
+1,491
+2% +$147K 0.4% 72
2017
Q1 		$5.91M Buy
60,465
+1,746
+3% +$167K 0.38% 71
2016
Q4 		$5.19M Buy
58,719
+1,704
+3% +$155K 0.35% 80
2016
Q3 		$5.5M Buy
57,015
+1,575
+3% +$150K 0.38% 75
2016
Q2 		$4.76M Buy
55,440
+852
+2% +$76.4K 0.33% 88
2016
Q1 		$4.75M Buy
54,588
+3,102
+6% +$277K 0.35% 84
2015
Q4 		$5.81M Buy
51,486
+4,098
+9% +$445K 0.46% 61
2015
Q3 		$4.79M Buy
47,388
+3,891
+9% +$467K 0.4% 76
2015
Q2 		$5.35M Buy
43,497
+6,315
+17% +$756K 0.43% 65
2015
Q1 		$4.26M Buy
37,182
+6,144
+20% +$678K 0.34% 88
2014
Q4 		$3.14M Buy
31,038
+10,098
+48% +$981K 0.26% 111
2014
Q3 		$1.91M Buy
20,940
+4,140
+25% +$363K 0.17% 155
2014
Q2 		$1.44M Buy
16,800
+2,562
+18% +$202K 0.13% 189
2014
Q1 		$1.12M Buy
14,238
+5,685
+66% +$474K 0.12% 210
2013
Q4 		$647K Buy
+8,553
New +$607K 0.07% 258

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KCM Investment Advisors's IBB Position: Q1 2026 in Review

KCM Investment Advisors reduced its iShares Biotechnology ETF (IBB) stake by 1.5% in Q1 2026, selling an estimated $35.1K and leaving 13,742 shares worth $2.32M. The position accounts for 0.08% of the portfolio, ranked #147.

KCM Investment Advisors first reported a position in IBB in Q4 2013 and has held it in 50 quarters since. The position peaked at $8.46M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • KCM Investment Advisors held 13,742 shares of iShares Biotechnology ETF worth $2.32M as of Q1 2026.
  • KCM Investment Advisors sold 205 iShares Biotechnology ETF shares in Q1 2026, an estimated $35.1K.
  • iShares Biotechnology ETF made up 0.08% of KCM Investment Advisors's portfolio in Q1 2026, its #147 holding.
  • KCM Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 50 quarters since.
  • KCM Investment Advisors's iShares Biotechnology ETF position peaked at $8.46M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on KCM Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.